2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Vasoproliferative Retinal Tumors
Vasoproliferative retinal tumors (VPRTs) are rare benign growths that arise from the retina, the light-sensitive tissue at the back of the eye. These tumors typically manifest as small, pinkish masses and can cause vision disturbances or even vision loss if they grow large enough to affect the central visual field. While VPRTs are not malignant, they can still pose significant challenges to vision and quality of life. Treatment options vary depending on the size and location of the tumor, ranging from observation to laser therapy or surgical intervention. Recent advancements in imaging techniques, such as optical coherence tomography (OCT) and fluorescein angiography, have improved our ability to diagnose and monitor VPRTs, leading to more personalized and effective treatment strategies. Ongoing research aims to further understand the underlying mechanisms driving VPRT development and to explore novel targeted therapies that can improve outcomes for affected individuals.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China